Install
- 245articles · 30d
- 1+ day agolatest article
- Aug 17, 2026earliest in window
- 0%with images
- 176avg words
- Economy, Business & Finance 241
- Finance & Business 237
- News 129
- Finance 92
- Business & Industrial 14
- Autos & Vehicles 4
- Industrial 3
- Transportation 3
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
CORRECTED FINANCIAL CALENDAR 2026
1+ day, 1+ hour ago (35+ words) view.news.eu.nasdaq.com AS "Amber Latvijas balzams" announces to publish its financial statements in the following order and dates: - 25.09.2026 Unaudited condensed financial statements for a six-month period ending on 30 June 2026...
Alzinova initiates operational start-up of global Phase 2 study with ALZ-101
3+ day, 22+ hour ago (241+ words) Next steps towards participant recruitmentWorldwide was appointed as the CRO for the Phase 2 study in June 2025 following an evaluation of several CROs with experience in Alzheimer’s disease clinical trials. Worldwide has extensive experience in neuroscience and dementia-related clinical trials. Since…...
Biosergen resolves on a set-off issue to guarantors in connection with the completed rights issue
3+ day, 22+ hour ago (117+ words) NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, WHETHER DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION WOULD BE PROHIBITED....
The Board of Directors of Alzinova resolves on a rights issue of units of approximately SEK 51 million
3+ day, 22+ hour ago (339+ words) Summary of the Rights Issue: In addition, ALZ-101 has received Investigational New Drug (IND) approval and Fast Track designation from the U.S. Food and Drug Administration (FDA). These regulatory advances represent an external validation of the program's potential and enable a…...
MAGLE GROUP COMPLETES SET-OFF ISSUE TO BONDHOLDERS AND THE DIRECTED SHARE ISSUES RESOLVED UPON BY THE EGM
3+ day, 22+ hour ago (94+ words) Allotment of shares in the Investor Share Issues Shares and share capital This press release is not a prospectus for the purposes of Regulation (EU) 2017/1129 (the "Prospectus Regulation") and has not been approved by any regulatory authority in any jurisdiction....
The Board of Directors implements a capital increase following the exercise of warrants
4+ day, 3+ hour ago (248+ words) 10.9.2026 15:58:38 CEST | Dataproces Group A/S | Company Announcement Company Announcement No. 16/2026 – The Board of Directors implements a capital increase following the exercise of warrants Pursuant to the authorisation granted to the Board of Directors under section 4.2.1 of the Company's Articles of…...
Zealand Pharma increases its share capital as a result of the exercise of employee warrants
4+ day, 2+ hour ago (266+ words) view.news.eu.nasdaq.com Company announcement – No. 47 / 2026 Zealand Pharma increases its share capital as a result of the exercise of employee warrants Copenhagen, Denmark, September 10, 2026 – Zealand Pharma A/S (“Zealand Pharma”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a biotechnology company transforming the…...
Notification on the increase of share capital of AS Agrova Baltics and Admission of Additional Shares to Nasdaq Riga Alternative Market First North
3+ day, 23+ hour ago (302+ words) On 9 July 2026, the Management Board of the Company adopted a resolution to issue 30,528 (thirty thousand five hundred twenty-eight) dematerialised shares, each with a nominal value of EUR 1.00 (one euro), with an aggregate nominal value of EUR 30,528 (thirty thousand five hundred…...
Final Terms
4+ day, 3+ hour ago (113+ words) Publication of Final Terms Not for release, publication or distribution, directly or indirectly, in or into the United States. Royal Bank of Canada today issued SGD 600,000,000 2.172 per cent. Covered Bonds due September 10, 2029, Series 78849 (the "Covered Bonds"), pursuant to the €75,000,000,000 Global…...
ESO CEO Renaldas Radvila resigns
4+ day, 23+ min ago (280+ words) view.news.eu.nasdaq.com AB „Ignitis grupė“ (hereinafter – Ignitis Group) informs that, as works to remedy the consequences of the record storm that hit Lithuania continue for a third week, an extraordinary meeting of the Board of Energijos skirstymo…...